QURE – uniQure N.V.
QURE — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
22.93
Margin Of Safety %
Put/Call OI Ratio
0.13
EPS Next Q Diff
-0.2
EPS Last/This Y
0.49
EPS This/Next Y
0.64
Price
17.13
Target Price
37.08
Analyst Recom
1.57
Performance Q
-24.26
Upside
-810.6%
Beta
0.79
Ticker: QURE
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | QURE | 17.97 | 0.16 | 0.11 | 318830 |
| 2026-03-10 | QURE | 18.27 | 0.17 | 0.15 | 315842 |
| 2026-03-11 | QURE | 17.6 | 0.18 | 0.14 | 317255 |
| 2026-03-12 | QURE | 16.95 | 0.18 | 0.24 | 316451 |
| 2026-03-13 | QURE | 16.94 | 0.18 | 0.27 | 316451 |
| 2026-03-17 | QURE | 15.64 | 0.18 | 0.72 | 319521 |
| 2026-03-18 | QURE | 14.74 | 0.18 | 0.06 | 320664 |
| 2026-03-19 | QURE | 15.27 | 0.18 | 0.18 | 321486 |
| 2026-03-20 | QURE | 16.12 | 0.18 | 0.12 | 322438 |
| 2026-03-23 | QURE | 15.89 | 0.13 | 0.89 | 262943 |
| 2026-03-24 | QURE | 15.17 | 0.12 | 0.07 | 263244 |
| 2026-03-25 | QURE | 16.4 | 0.12 | 0.16 | 265110 |
| 2026-03-26 | QURE | 15.61 | 0.13 | 0.87 | 267282 |
| 2026-03-27 | QURE | 14.79 | 0.13 | 0.19 | 268179 |
| 2026-03-30 | QURE | 14.78 | 0.13 | 1.04 | 269132 |
| 2026-03-31 | QURE | 16.36 | 0.13 | 0.07 | 268848 |
| 2026-04-01 | QURE | 16.9 | 0.13 | 0.73 | 270799 |
| 2026-04-02 | QURE | 17.13 | 0.13 | 0.50 | 272539 |
| 2026-04-06 | QURE | 17.37 | 0.13 | 0.07 | 273118 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | QURE | 17.97 | -6.3 | 141.9 | -2.98 |
| 2026-03-10 | QURE | 18.26 | -6.3 | 38.6 | -2.98 |
| 2026-03-11 | QURE | 17.57 | -6.3 | 45.4 | -2.98 |
| 2026-03-12 | QURE | 16.95 | -6.3 | 51.5 | -2.98 |
| 2026-03-13 | QURE | 15.53 | -2.9 | 65.8 | -2.97 |
| 2026-03-17 | QURE | 15.62 | -2.9 | 64.8 | -2.97 |
| 2026-03-18 | QURE | 14.74 | -2.9 | 73.6 | -2.97 |
| 2026-03-19 | QURE | 15.29 | -2.9 | 68.1 | -2.97 |
| 2026-03-20 | QURE | 16.09 | -2.9 | 60.2 | -2.97 |
| 2026-03-23 | QURE | 15.90 | -2.9 | 62.1 | -2.97 |
| 2026-03-24 | QURE | 15.18 | -2.9 | 69.3 | -2.97 |
| 2026-03-25 | QURE | 16.40 | -2.9 | 57.0 | -2.97 |
| 2026-03-26 | QURE | 15.61 | -2.9 | 65.0 | -2.97 |
| 2026-03-27 | QURE | 14.81 | -2.9 | 72.9 | -2.97 |
| 2026-03-30 | QURE | 14.75 | -4.0 | 73.6 | -2.97 |
| 2026-03-31 | QURE | 16.34 | -4.0 | 57.7 | -2.97 |
| 2026-04-01 | QURE | 16.91 | -4.0 | 52.0 | -2.97 |
| 2026-04-02 | QURE | 17.15 | -4.0 | 49.5 | -2.97 |
| 2026-04-06 | QURE | 17.39 | -4.0 | 47.1 | -2.97 |
| 2026-04-07 | QURE | 17.13 | -4.0 | 52.0 | -2.97 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | QURE | -6.87 | 9.93 | 19.34 |
| 2026-03-10 | QURE | -6.87 | 9.93 | 19.34 |
| 2026-03-11 | QURE | -6.87 | 9.93 | 22.75 |
| 2026-03-12 | QURE | -6.87 | 9.93 | 22.75 |
| 2026-03-13 | QURE | -6.87 | 9.93 | 22.75 |
| 2026-03-17 | QURE | -6.87 | 10.23 | 22.75 |
| 2026-03-18 | QURE | -6.87 | 10.23 | 22.75 |
| 2026-03-19 | QURE | -6.87 | 10.23 | 22.75 |
| 2026-03-20 | QURE | -6.87 | 10.23 | 22.75 |
| 2026-03-23 | QURE | -6.87 | 10.24 | 22.75 |
| 2026-03-24 | QURE | -6.87 | 10.24 | 22.75 |
| 2026-03-25 | QURE | -6.87 | 10.24 | 22.93 |
| 2026-03-26 | QURE | -6.87 | 10.24 | 22.93 |
| 2026-03-27 | QURE | -3.29 | 10.24 | 22.93 |
| 2026-03-30 | QURE | -3.29 | 10.22 | 22.93 |
| 2026-03-31 | QURE | -3.29 | 10.22 | 22.93 |
| 2026-04-01 | QURE | -3.29 | 10.22 | 22.93 |
| 2026-04-02 | QURE | -3.29 | 10.22 | 22.93 |
| 2026-04-06 | QURE | -3.29 | 10.22 | 22.93 |
| 2026-04-07 | QURE | -3.29 | 10.22 | 22.93 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.56
Avg. EPS Est. Current Quarter
-0.76
Avg. EPS Est. Next Quarter
-0.76
Insider Transactions
-3.29
Institutional Transactions
10.22
Beta
0.79
Average Sales Estimate Current Quarter
4
Average Sales Estimate Next Quarter
5
Fair Value
Quality Score
41
Growth Score
32
Sentiment Score
61
Actual DrawDown %
76
Max Drawdown 5-Year %
-90.1
Target Price
37.08
P/E
Forward P/E
PEG
P/S
65.58
P/B
5.37
P/Free Cash Flow
EPS
-3.48
Average EPS Est. Cur. Y
-2.97
EPS Next Y. (Est.)
-2.33
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-1236
Relative Volume
0.33
Return on Equity vs Sector %
-127.5
Return on Equity vs Industry %
-111
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.22
EBIT Estimation
52
◆
QURE
Healthcare
$17.14
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
51.1
Range 1M
59.9%
Sup Dist
1.2%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-1%
EPS NY
15.6%
52W%
14.8%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+116.3% upside
Upside
+116.3%
Quality
41
uniQure N.V.Sector: Healthcare
Industry: Biotechnology
Employees: 221
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
QURE
Latest News
—
Caricamento notizie per QURE…
stock quote shares QURE – uniQure N.V. Stock Price stock today
news today QURE – uniQure N.V. stock forecast ,stock prediction 2023 2024 2025
marketwatch QURE – uniQure N.V. yahoo finance google finance
stock history QURE – uniQure N.V. invest stock market
stock prices QURE premarket after hours
ticker QURE fair value insiders trading